STESOLID

This brand name is authorized in Austria, Spain, Finland, Hong Kong, Ireland, Malta, Netherlands, New Zealand, Singapore, United Kingdom

Active ingredients

The drug STESOLID contains one active pharmaceutical ingredient (API):

1 Diazepam UNII Q3JTX2Q7TU - DIAZEPAM

Diazepam is a psychotropic substance from the class of 1,4-benzodiazepines with marked properties of suppression of tension, agitation and anxiety as well as sedative and hypnotic effects. In addition, diazepam demonstrates muscle relaxant and anticonvulsive properties. It is used in the short-term treatment of anxiety and tension states, as a sedative and premedicant, in the control of muscle spasm and in the management of alcohol withdrawal symptoms. Read about Diazepam

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05BA01	Diazepam	N Nervous system → N05 Psycholeptics → N05B Anxiolytics → N05BA Benzodiazepine derivatives
Discover more medicines within N05BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 58000, 58001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 573698, 582275
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 26385, 26401
Country: HK	Department of Health Drug Office	Identifier(s): 46416, 46417
Country: IE	Health Products Regulatory Authority	Identifier(s): 45489, 45497
Country: MT	Medicines Authority	Identifier(s): AA729/04702
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 7390, 7404
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1694, 1695
Country: SG	Health Sciences Authority	Identifier(s): 02309P